PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 22 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $964,000 | -7.9% | 914,000 | 0.0% | 0.02% | -10.0% |
| Q1 2019 | $1,047,000 | -87.6% | 914,000 | -89.0% | 0.02% | -74.0% |
| Q4 2018 | $8,426,000 | +80.9% | 8,280,000 | +76.4% | 0.08% | +22.2% |
| Q3 2018 | $4,657,000 | -0.3% | 4,695,000 | -7.2% | 0.06% | -3.1% |
| Q2 2018 | $4,670,000 | -22.3% | 5,060,000 | -13.8% | 0.06% | -31.6% |
| Q1 2018 | $6,008,000 | +24.3% | 5,870,000 | +17.4% | 0.10% | +25.0% |
| Q4 2017 | $4,834,000 | -32.2% | 5,000,000 | -25.0% | 0.08% | -29.0% |
| Q3 2017 | $7,135,000 | -1.6% | 6,665,000 | -16.7% | 0.11% | -10.1% |
| Q2 2017 | $7,253,000 | – | 8,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 12,804,000 | $12,636,000 | 21.66% |
| Context Partners Fund, L.P. | 7,175,000 | $7,034,000 | 4.09% |
| Context Capital Management, LLC | 7,175,000 | $7,034,000 | 4.09% |
| Pinnacle Holdings, LLC | 3,260,000 | $3,217,213,000 | 1.11% |
| Venator Capital Management Ltd. | 2,000,000 | $1,960,000 | 0.98% |
| LINDEN ADVISORS LP | 26,617,000 | $26,292,000 | 0.80% |
| WHITEBOX ADVISORS LLC | 21,681,000 | $21,396,000 | 0.65% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $16,518,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,695,000 | $4,657,000 | 0.06% |
| AQR Arbitrage LLC | 3,150,000 | $3,124,000 | 0.04% |